These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6147520)

  • 1. Cutaneous malignant lymphoma with dual B and T cell markers.
    Dreno B; Stalder JF; Bureau B; Litoux P; Barriere H
    Lancet; 1984 Aug; 2(8400):459. PubMed ID: 6147520
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibody patterns in cutaneous lymphoid infiltrates. Their possible relevance to the diagnosis and categorization of cutaneous lymphomas.
    McMillan EM
    Dermatol Clin; 1985 Oct; 3(4):593-603. PubMed ID: 2947768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BE-2 antigen: appearance in activation and long-term growth of T cells.
    Heald PW; Berger CL; Yamamura T; McNamara J; Edelson RL
    J Invest Dermatol; 1990 Apr; 94(4):452-5. PubMed ID: 2313117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell markers in malignant B-cell lymphoma with scleroderma-like manifestation.
    Van Joost T; Stolz E; Blog FB; Van der Kwast TH; Vuzevski VD; Van Dongen JM
    J Cutan Pathol; 1984 Dec; 11(6):495-500. PubMed ID: 6335153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of proliferation-associated antigens in cutaneous lymphoid infiltrates].
    Baba N
    Nihon Hifuka Gakkai Zasshi; 1990 Apr; 100(5):567-73. PubMed ID: 2395218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formalin-resistant leukocyte surface antigens in the diagnosis of cutaneous malignant lymphomas.
    Hauschild A; Sterry W
    Am J Pathol; 1989 Jul; 135(1):177-84. PubMed ID: 2774058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of cell surface properties by flow-cytometry in malignant lymphoma].
    Uemura H; Komatsu M; Itagaki M; Fukui Y
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):385-7. PubMed ID: 3970559
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies of cutaneous malignant lymphoma--especially about T gamma cell (author's transl)].
    Shimokawa Y
    Nihon Hifuka Gakkai Zasshi; 1982 Feb; 92(2):149-55. PubMed ID: 6979648
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes.
    Grogan TM; Fielder K; Rangel C; Jolley CJ; Wirt DP; Hicks MJ; Miller TP; Brooks R; Greenberg B; Jones S
    Am J Clin Pathol; 1985 Mar; 83(3):279-88. PubMed ID: 2983525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma.
    Medeiros LJ; Picker LJ; Abel EA; Hu CH; Hoppe RT; Warnke RA; Wood GS
    J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):929-42. PubMed ID: 2808829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MY7 monoclonal antibody for diagnosis of cutaneous T-cell lymphoma.
    Dreno B; Bureau B; Stalder JF; Litoux P
    Arch Dermatol; 1990 Nov; 126(11):1454-6. PubMed ID: 2146925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional status of lymphocytes from the lymph nodes of patients with malignant lymphomas of the skin].
    Shaposhnikov OK; Genter EI; Rodionov AN
    Vestn Dermatol Venerol; 1982 Aug; (8):4-7. PubMed ID: 7148128
    [No Abstract]   [Full Text] [Related]  

  • 13. Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.
    Wagner SN; Wagner C; Reinhold U; Funk R; Zöller M; Goos M
    J Invest Dermatol; 1998 Sep; 111(3):464-71. PubMed ID: 9740242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In situ - demonstration of helper-T-lymphocytes in cutaneous malignant lymphomas by diaminopeptidase IV (DAP IV)].
    Sterry W; Steigleder GK; Goos M; Meisterernst E
    Z Hautkr; 1982 Apr; 57(8):567-76. PubMed ID: 6124066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte differentiation and malignant lymphoma.
    Kikuchi K; Ishii Y; Koshiba H
    Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1384-94. PubMed ID: 7342645
    [No Abstract]   [Full Text] [Related]  

  • 16. Case report of adult T-cell leukemia with preceding long-standing cutaneous involvement.
    Kikuchi M; Mitsui T; Kozuru M; Uike N; Kurata T; Katsuta Y
    Jpn J Clin Oncol; 1983; 13 Suppl 2():201-7. PubMed ID: 6603528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological characterization of malignant epidermotropic lymphoma cells in cutaneous infiltrates (author's transl)].
    Thivolet J; Souteyrand P; Alario A; Schmitt D; Perrot H
    Dermatologica; 1978; 157(6):357-64. PubMed ID: 363474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101.
    Shawler DL; Miceli MC; Wormsley SB; Royston I; Dillman RO
    Cancer Res; 1984 Dec; 44(12 Pt 1):5921-7. PubMed ID: 6333922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non T lymphoid cells can express T cell surface characteristics: normal, HCL, and a range of leukemic B cells express T cell antigens after appropriate in vitro stimulation.
    Worman CP; Mills KH; Cawley JC
    Semin Oncol; 1984 Dec; 11(4):401-4. PubMed ID: 6334367
    [No Abstract]   [Full Text] [Related]  

  • 20. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
    Aisenberg AC
    N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.